Potential COVID-19 treatment: Singapore participating in global trial of remdesivir drug

There are no approved treatments for COVID-19, but those used for other diseases are being studied to see if they can be used. Remdesivir is an antiviral drug that is undergoing clinical trials as a potential COVID-19 treatment. Singapore is taking part in the global Phase III trial, and the participants include the National Centre for Infectious Diseases (NCID), National University Hospital (NUH) and Singapore General Hospital (SGH). Associate Professor David Lye from the Infectious Disease Research and Training Office at NCID shared more about remdesivir trial.

Subscribe to our channel here: https://cna.asia/youtubesub

Subscribe to our news service on Telegram: https://cna.asia/telegram

Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook: https://www.facebook.com/channelnewsasia
Instagram: https://www.instagram.com/channelnewsasia
Twitter: https://www.twitter.com/channelnewsasia

Видео Potential COVID-19 treatment: Singapore participating in global trial of remdesivir drug канала CNA